Is This a Possible Molecular Trigger of ALS?
King’s College London researchers have identified a new hallmark of ALS, revealing a likely molecular trigger of the disease.
Category: ALS
ALS
Latest
ALS
Latest
FDA Approves First ALS Treatment Funded by Ice Bucket Challenge
ALS Association invested $2.2 million raised by social media movement Ice Bucket Challenge into development and trial of AMX0035.
ALS
Latest
Patients with ALS Are Not Only Troubled by Muscle Weakness and Respiratory Dysfunction
Non-motor symptoms such as pain, fatigue, and sleep disorders, are observed in patients with ALS and reduce their quality of life.
Stealth BioTherapeutics Presents ALS Therapy Data at Keystone Neurodegeneration Symposium
Stealth BioTherapeutics Corp presents SBT-272 preclinical data demonstrating improvement in upper neuron function in ALS.
Read More
Muscular Dystrophy Association Celebrates Lou Gehrig Day at Major League Baseball Games in June
The Muscular Dystrophy Association will honor Major League Baseball’s recognition of Lou Gehrig Day at games across the country in June.
Read More
Team Gleason Partners with Synchron to Redefine Accessibility
Team Gleason and Synchron announce a partnership agreement to provide patient-focused feedback on their platform to transform daily life.
Read More
n-Lorem Foundation and Columbia University Establish Silence ALS Initiative
Silence ALS initiative will offer an integrated solution to identify, support and potentially treat nano-rare ALS patients.
Read More
ProMIS Neurosciences Reports New Milestones in Potential Therapeutic Approaches for ALS
ProMIS Neurosciences Inc announces new milestones in potential therapeutic approaches for ALS, the company notes in a media release.
Read More
Target ALS Names Winner of Rebecca Luker Courage Award
Target ALS announces Merit E. Cudkowicz as the winner of the first annual Target ALS Rebecca Luker Courage Award.
Read More
Muscular Dystrophy Association Accelerates Research, Advances Care, and Advocates to End ALS
MDA announces programming and events in support of people living with ALS throughout ALS Awareness Month in May.
Read More
Mutations in Noncoding DNA Protect the Brain from ALS
Weizmann Institute of Science researchers link a new gene to ALS that plays a defensive, rather than an offensive, role in the disease.
Read More
Researchers ID Potential ALS Treatment Window
Johns Hopkins Medicine researchers have found a possible window of opportunity during ALS treatment to target astrocyte abnormalities.
Read More
Study: Brain Implants Safe, May Help Those with Paralysis Use Computer for Daily Tasks
A brain-computer interface (aka brain implant) is safe and allows participants to use a computer to communicate by text and do daily tasks.
Read More
Hybrid Assistive Limb (HAL) Helps Improve Gait Ability in Patients with ALS
Professor Kano Osamu, MD, PhD, and his colleagues conducted a study to evaluate the effect of HAL-based training in ALS patients.
Read More
Is it Possible to Slow the Progression of Muscle Degeneration in ALS Patients?
Researchers from University of Arizona are investigating an oral drug candidate that may benefit patients with Lou Gehrig’s disease, or ALS.
Read More
Clene Nanomedicine Presents Updated Clinical Data at MDA Conference
Clene Nanomedicine Inc presents results from Phase 2 RESCUE-ALS and REPAIR trials and preclinical data in ALS at the 2022 MDA Conference.
Read More
Grant-Funded Research Project Aims to Deliver ‘Precision Medicine’ for Motor Neuron Disease
A research program launched recently in Trinity College Dublin aims to provide new insights regarding Motor Neuron Disease, also known as ALS.
Read More
Adaptive HEALEY ALS Platform Trial Hopes to Bring New Treatments to Patients Faster
A study describes the approach, structure, and launch of the HEALEY ALS Platform Trial, designed to accelerate the development of treatments.
Read More